Skip to main content
search

The 90+ Study on 60 Minutes this Sunday

By November 20, 2020Commentary, In the News

The 90+ Study, co-led by UCI MIND faculty members Drs. Claudia Kawas and Maria Corrada, will be featured in the show “60 Minutes” this Sunday, November 22 on CBS.

The episode will be a follow-up of the study participants who were featured on the show six years ago and an update on research findings since then.

Learn more about the feature in the articles below:

Related posts:

  1. FDA delays decision on donanemab The FDA today announced that it will convene an advisory panel to review the data submitted to support potential approval of donanemab, a monoclonal antibody against the beta amyloid protein that demonstrated efficacy in early Alzheimer’s disease in a recent Phase 3 clinical trial. A positive decision to approve donanemab...
  2. FDA Advisory Panel meeting held to consider potential approval of donanemab Today, the FDA convened its Peripheral and Central Nervous System Drugs Advisory Committee to review the data from pivotal clinical trials of donanemab, a monoclonal antibody against the beta amyloid protein that accumulates in the brain of people with Alzheimer’s disease. One of these trials was conducted at UCI MIND....
  3. AlzForum provides update on MODEL-AD at UCI AlzForum, the popular online publication for Alzheimer’s researchers, published a summary of recent advances from the MODEL-AD teams and highlighted the work of the principal investigators at UCI, Drs. Kim Green, Andrea Tenner, and Frank LaFerla.  The article also called attention to innovative research in the Green Lab, including work...
Close Menu